Concord, CA, United States of America

Matthew Ross Drever

This inventor holds 2 USPTO granted patents. Top assignees: Pfizer Corporation, University of California. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Ross Drever. Retrieved from https://idiyas.com/inventor/matthew-ross-drever

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Matthew Ross Drever: Innovator in Cancer Treatment

Introduction

Matthew Ross Drever is a notable inventor based in Concord, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies. With a total of 2 patents, Drever's work focuses on the application of anti-AV8 antibodies in medical treatments.

Latest Patents

Drever's latest patents include a method of treating cancer using anti-AV8 antibodies. This invention provides antibodies and antigen-binding fragments that specifically bind to αvβ8 integrin. The invention encompasses various uses and associated methods of utilizing these antibodies. Another significant patent is for anti-AVB8 antibodies and compositions, which also specifically bind to αvβ8 integrin, including their uses and methods of application.

Career Highlights

Throughout his career, Drever has worked with prominent organizations such as Pfizer Corporation and the University of California. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Drever has collaborated with notable colleagues, including Kyle Steven Niessen and Dharmaraj Samuel, enhancing the impact of his work through teamwork and shared expertise.

Conclusion

Matthew Ross Drever's innovative contributions to cancer treatment through his patents and collaborations highlight his dedication to advancing medical science. His work continues to inspire future research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…